Stephen Kanes
CIK 1612859 · Chief Medical Officer · last filed 2026-02-03
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$4.77M
Companies
2
Total Filings
27
Lifetime Open-Market Net
-$14.44M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| CNTA | Chief Medical Officer | 120,000 | $39.72 | $4.77M | $0 | 2 | 2026-02-03 |
| Sage Therapeutics, Inc. (SAGE) Delisted | Chief Medical Officer | 14,591 | $8.68 | $126.6K | -$14.44M | 25 | 2021-10-21 |
Recent Filings · Page 2 of 3
27 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2019-02-15 | Sage Therapeutics, Inc. (SAGE) Delisted | Grant (A) | — | $0 | EDGAR |
| 2019-02-08 | Sage Therapeutics, Inc. (SAGE) Delisted | Sell (S) | −22,948 | -$3.44M | EDGAR |
| 2018-12-11 | Sage Therapeutics, Inc. (SAGE) Delisted | Grant (A) | — | $0 | EDGAR |
| 2018-04-04 | Sage Therapeutics, Inc. (SAGE) Delisted | Grant (A) | — | $0 | EDGAR |
| 2018-01-12 | Sage Therapeutics, Inc. (SAGE) Delisted | Mixed | −24,000 | -$7.79M | EDGAR |
| 2017-02-08 | Sage Therapeutics, Inc. (SAGE) Delisted | Grant (A) | — | $0 | EDGAR |
| 2016-12-16 | Sage Therapeutics, Inc. (SAGE) Delisted | Grant (A) | — | $0 | EDGAR |
| 2016-04-21 | Sage Therapeutics, Inc. (SAGE) Delisted | Mixed | — | -$788.5K | EDGAR |
| 2016-02-10 | Sage Therapeutics, Inc. (SAGE) Delisted | Grant (A) | — | $0 | EDGAR |
| 2015-09-29 | Sage Therapeutics, Inc. (SAGE) Delisted | Mixed | +15,000 | -$269.1K | EDGAR |
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.